Alfresa Holdings
2784.TTSE PRIMEWholesale Trade
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥19.5bn | ¥20.5bn | ¥17.3bn | ¥22.2bn | ¥17.2bn | ¥25.3bn |
| Operating income | ¥15.9bn | ¥18.0bn | ¥14.8bn | ¥20.1bn | ¥15.2bn | ¥23.4bn |
| Ordinary income | ¥15.8bn | ¥18.0bn | ¥14.2bn | ¥20.3bn | ¥15.4bn | ¥23.7bn |
| Total assets | ¥275.6bn | ¥272.8bn | ¥266.9bn | ¥271.9bn | ¥265.3bn | ¥277.5bn |
| Net assets / equity | ¥220.4bn | ¥219.0bn | ¥223.4bn | ¥256.8bn | ¥247.6bn | ¥261.3bn |
| EPS (basic) | ¥92.26 | ¥98.99 | ¥69.32 | ¥100.79 | ¥64.88 | ¥112.78 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 4
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 47 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 71 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 45 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 201 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Dispensing Pharmacy And Related Businesses | ¥37.2bn | ¥499m |
| Ethical Pharmaceuticals Wholesaling Business | ¥2.76T | ¥33.3bn |
| Manufacturing Business | ¥37.2bn | ¥1.2bn |
| Self Medication Products Wholesaling Business | ¥266.6bn | ¥3.0bn |
| Other segments | — | −¥1.1bn |
| Adjustments & eliminations | — | −¥749m |
| Total | ¥3.10T | ¥38.0bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.